| dc.contributor.author | BENNETT, KATHLEEN | en |
| dc.date.accessioned | 2015-01-06T10:33:18Z | |
| dc.date.available | 2015-01-06T10:33:18Z | |
| dc.date.created | 2013 | en |
| dc.date.issued | 2013 | en |
| dc.date.submitted | 2013 | en |
| dc.identifier.citation | Godman, B. Persson, M. Miranda, J. Barbui, C. Bennie, M. Bennett, K. Bucsics, A. Simoens, S. Zara, C. Gustafsson, L.L., PP262-Can authorities take full advantage of the availability of generic atypical antipsychotic drugs? implications for the future, Clinical Therapeutics, 35, 8, Supplement, 2013, e99 - e100 | en |
| dc.identifier.issn | 0149-2918 | en |
| dc.identifier.other | Y | en |
| dc.identifier.uri | http://hdl.handle.net/2262/72912 | |
| dc.description | PUBLISHED | en |
| dc.format.extent | e99 | en |
| dc.format.extent | e100 | en |
| dc.language.iso | en | en |
| dc.relation.ispartofseries | Clinical Therapeutics | en |
| dc.relation.ispartofseries | 35 | en |
| dc.relation.ispartofseries | 8, Supplement | en |
| dc.rights | Y | en |
| dc.subject | antipsychotic drugs | en |
| dc.title | PP262-Can authorities take full advantage of the availability of generic atypical antipsychotic drugs? implications for the future | en |
| dc.title.alternative | The Proceedings of the 11th Conference of the European Association for Clinical Pharmacology and Therapeutics | en |
| dc.type | Journal Article | en |
| dc.type.supercollection | scholarly_publications | en |
| dc.type.supercollection | refereed_publications | en |
| dc.identifier.peoplefinderurl | http://people.tcd.ie/bennettk | en |
| dc.identifier.rssinternalid | 98523 | en |
| dc.identifier.doi | http://dx.doi.org/10.1016/j.clinthera.2013.07.291 | en |
| dc.rights.ecaccessrights | openAccess | |
| dc.identifier.rssuri | http://www.sciencedirect.com/science/article/pii/S0149291813006747 | en |
